相关实验视频

Updated: Jun 3, 2025

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

慢性GIPR激应导致胰腺小岛GIPR功能脱敏

Iona Davies¹, Alice E Adriaenssens², William R Scott³

¹Section of Endocrinology and Investigative Medicine, Imperial College London, United Kingdom.

Molecular metabolism

|January 9, 2025

概括

持续暴露于依赖葡萄糖的胰岛素多受体 (GIPR) 激动剂会导致胰腺小岛的功能脱敏,这可能会影响长期的肥胖和糖尿病治疗. 需要进一步的研究来了解人类的GIPR脱敏性.

科学领域:

代谢药理学代谢药理学
内分泌学在内分泌学.
受体的药理学受体的药理学

背景情况:

人们对针对依赖葡萄糖的胰岛素型多受体 (GIPR) 来治疗肥胖和2型糖尿病的治疗重新感兴趣.
与G蛋白结合受体脱敏可能会限制GIPR激活剂的长期疗效,类似于葡萄糖类1受体 (GLP-1R) 激活剂.

研究的目的:

为了调查胰腺GIPR功能脱敏度在持续的激动剂暴露后的程度.
评估GIPR无敏化对治疗疗效的影响.

主要方法:

一种长期作用的GIPR激活剂,GIP108,被用来通过活细胞成像来评估分散的胰腺小岛中的cAMP反应.
受体内部化和β-arrestin-2激活在体外进行了研究.
在体内,通过小鼠的腹腔内葡萄糖耐受性测试来评估体内脱敏性.

主要成果:

在小鼠中,GIP108治疗导致体重减轻和改善葡萄糖平衡.
长时间暴露于GIPR激动剂诱导了孤立小岛的同源功能脱敏.
在体内GIP108预处理减少了随后GIP重新挑战的抗高血糖反应,与最小的受体内化或β-arrestin-2激活.

结论:

慢性GIP108治疗改善了葡萄糖耐受性,但导致部分胰腺岛 GIPR 脱敏.
降低脱敏潜力的联体可能会改善体内疗效.
了解人类胰腺GIPR脱敏感性对于开发有效的代谢药物疗法至关重要.

关键词:

葡萄糖依赖型胰岛素型多受体 (GIPR)肥胖问题肥胖问题感受体脱敏化感受体脱敏化受体内化是受体内化的.2 型糖尿病 2 型糖尿病这是一种β-arrestin.

更多相关视频

Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol

Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol

Published on: November 3, 2023

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Published on: May 2, 2025

相关概念视频

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

GPCR Desensitization

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...

Desensitization and Tachyphylaxis

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.